CVS Health Corporation (NYSE:CVS) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Larry McGrath - SVP, Business Development and IR Karen Lynch - President and CEO Shawn Guertin - EVP and Chief Financial Officer Kyle Armbrester - CEO, Signify Health Mike Pykosz - CEO, Oak Street Health Daniel Finke - EVP and President, Health Care Benefits Michelle Peluso - EVP and Chief Customer Officer and Retail Co-President Prem Shah - EVP and Chief Pharmacy Officer and Retail Co-President Da ...

First quarter 2023 Earnings conference call ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission File Number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (Sta ...

CVS Health Corporation (NYSE:CVS) Q4 2022 Earnings Conference Call February 8, 2023 8:00 AM ET Company Participants Tom Cowhey - Senior Vice President, Capital Markets Karen Lynch - President and Chief Executive Officer Shawn Guertin - Executive Vice President and Chief Financial Officer Mike Pykosz - Chairman, Chief Executive Officer and Co-Founder, Oak Street Health Daniel Finke - President, Healthcare Benefits Michelle Peluso - Chief Customer Officer and Retail Co-President Prem Shah - Chief Pharmacy Off ...

FOURTH QUARTER 2022 Earnings conference call February 8, 2023 KAREN S. LYNCH President ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...

Oak Street Health, Inc J.P. Morgan Healthcare Conference Disclaimer The presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding Oak Street Health, Inc.’s (the “Company”) future growth and our financial outlook for the fiscal year 2023. Forwar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission File Number: 001-01011 ♥CVSHealth CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware ...

CVS Health Corporation (NYSE:CVS) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Larry McGrath - Senior Vice President Business Development and Investor Relations | Karen Lynch - President and Chief Executive Officer Shawn Guertin - Executive Vice President and Chief Financial Officer Alan Lotvin - President, Pharmacy Services Dan Finke - President, Healthcare Benefits Michelle Peluso - Executive Vice President. Chief Customer Officer and Co-President, Retail Prem Shah - Exe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission File Number: 001-01011 ♥CVSHealth CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-04 ...